Adocia
Products and platforms
- Pipeline
- Technology Platforms
Careers
Partnering
Investors
Media
Contact
- Contact us
- Map and accessibility

Investors
Media
- Press releases
- Media

EN
- FR

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

Previous articleADOCIA Announces Third-quarter Financial 2014 Results

Next articleADOCIA: shareholder newsletter and invitation to two conference calls today and tomorrow

Adocia
Products and platforms
Careers
Partnering
Investors
Media
Contact

Contact us

+33(0)4 72 610 610 contact@adocia.com

Adocia
115 Avenue Lacassagne
69003 Lyon, France

2026 © Adocia

Site plan
Legal notice
Privacy policy and cookies policy
Managing cookies

Website by

Un Brin de Campagne